Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
beta-lactamase inhibitor |
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
J01DI54
|
| gptkbp:brand |
gptkb:Recarbrio
|
| gptkbp:CASNumber |
1390772-77-9
|
| gptkbp:combines |
gptkb:cilastatin
gptkb:imipenem |
| gptkbp:developer |
gptkb:Merck_&_Co.
|
| gptkbp:hasMolecularFormula |
C12H13N4O5S
|
| https://www.w3.org/2000/01/rdf-schema#label |
relebactam
|
| gptkbp:mechanismOfAction |
inhibits class A and C beta-lactamases
|
| gptkbp:PubChem_CID |
71545361
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:UNII |
6Q1K7K2F1X
|
| gptkbp:usedFor |
treatment of ventilator-associated bacterial pneumonia
treatment of complicated urinary tract infections treatment of hospital-acquired bacterial pneumonia |
| gptkbp:bfsParent |
gptkb:Recarbrio
|
| gptkbp:bfsLayer |
5
|